Vimarsana
Biggest News Aggregation in the World

Page 13 - Clinical Testing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Testing Today - Breaking & Trending Today

European Biosimilar Market Report 2022-2027: Government Policies Incentivising Biosimilars Driving Demand - Vimarsana News

European Biosimilar Market Report 2022-2027: Government Policies Incentivising Biosimilars Driving Demand

/PRNewswire/ -- The "Biosimilar Market in Europe: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...

5 new application eBooks to advance your research - Vimarsana News

5 new application eBooks to advance your research

Discover free downloads on the latest methods for spatial biology, ELISA applications, amino acid analysis, and more

The Worldwide Cell Analysis Industry is Projected to Reach $28.6 Billion by 2027 - Vimarsana News

The Worldwide Cell Analysis Industry is Projected to Reach $28.6 Billion by 2027

/PRNewswire/ -- The "Cell Analysis Market by Product & Service (Reagents & Consumables, Instruments), Technique (Flow Cytometry, High Content Screening),...

First-in-class, anti-cancer mitochondrial drug found to be effective against most carcinoma cell lines - Vimarsana News

First-in-class, anti-cancer mitochondrial drug found to be effective against most carcinoma cell lines

A study of the lead agent (CPI-613) in a class of anticancer drugs undergoing Food and Drug Administration (FDA) approved clinical trials reveals that CPI-613 is effective against most carcinoma cell lines, and, used in combination, could have efficacy against reducing some tumors.

Inner Circle: Filling the void in care for children on the spectrum - Vimarsana News

Inner Circle: Filling the void in care for children on the spectrum

Sajida Foundation’s Inner Circle collaborates with a Singaporean organisation to provide early interventions for children with autism spectrum disorders (ASD) or developmental delays